Sumitomo Pharma Executive and Leadership Team

Shinichiro Katayanagi, the Chair and Chief Executive Officer at Sumitomo Pharma, directs the overarching corporate strategy and long-term vision for the organization. Katayanagi oversees the integration of cutting-edge research and development activities across the core therapeutic areas of psychiatry, neurology, and oncology. By aligning internal resources with global market demands, the Chair and Chief Executive Officer ensures the successful commercialization of innovative pharmaceutical products. This leadership role involves constant engagement with the Board to maintain high standards of corporate governance and operational excellence. Shinichiro Katayanagi drives the expansion of frontier business initiatives, seeking new healthcare solutions that address complex social issues beyond traditional medicine. Through rigorous oversight of international operations, the Chair and Chief Executive Officer secures the company's competitive position in the global pharmaceutical landscape while fostering a culture of scientific advancement and sustainable growth across all regional markets.

Jennifer Henderson, the Senior Director, CSS & Toq Chief of Staff at Sumitomo Pharma, manages the operational synchronization between corporate support services and specialized technical teams. Henderson coordinates cross-functional workflows to ensure that R&D activities in regenerative medicine and cell therapy remain on schedule and within budgetary constraints. By facilitating communication between executive leadership and departmental heads, the Senior Director, CSS & Toq Chief of Staff optimizes internal processes to support the company's mission of creating innovative pharmaceutical products. Jennifer Henderson monitors the execution of strategic projects, providing the necessary administrative infrastructure to drive efficiency across the organization. This role involves managing complex organizational transitions and ensuring that all support functions align with the broader goals of the company. Through meticulous planning and resource allocation, the Senior Director, CSS & Toq Chief of Staff maintains the operational stability required to advance the company's diverse portfolio of healthcare solutions.

Armin Szegedi, the Chief Medical Officer at Sumitomo Pharma, leads the clinical development and medical strategy for the entire product pipeline. Szegedi oversees the rigorous testing and validation of new therapies within the psychiatry, neurology, and oncology sectors, ensuring compliance with global health standards. By directing clinical trials and medical affairs, the Chief Medical Officer validates the efficacy and safety of innovative pharmaceutical products before market entry. Armin Szegedi collaborates with regulatory bodies and scientific partners to advance the company's research in infectious disease and regenerative medicine. This leadership position requires constant evaluation of medical data to inform strategic R&D decisions and support the commercialization of new healthcare solutions. Through the oversight of medical teams, the Chief Medical Officer ensures that all clinical activities align with the company's commitment to addressing unmet patient needs. Szegedi maintains the scientific integrity of the organization while driving the development of life-changing medical interventions.

Tara Soni, the Chief Legal Officer at Sumitomo Pharma, manages all legal affairs, intellectual property protection, and regulatory compliance for the global enterprise. Soni oversees the legal framework surrounding the development and commercialization of pharmaceutical products, ensuring that all R&D activities adhere to international laws and ethical standards. By providing counsel on complex contractual agreements and corporate governance, the Chief Legal Officer mitigates risk and protects the company's interests in the competitive pharmaceutical market. Tara Soni directs the legal strategy for the company's frontier business initiatives, facilitating the expansion into new healthcare solutions. This role involves close collaboration with the executive team to navigate the legal complexities of global health operations and intellectual property rights. Through the proactive management of legal challenges, the Chief Legal Officer ensures that the organization maintains its reputation for integrity and compliance while pursuing its mission of continuous innovation in medicine and technology.